Variable Features of Juvenile Polyposis Syndrome With Gastric Involvement Among Patients With a Large Genomic Deletion of BMPR1A.


Journal

Clinical and translational gastroenterology
ISSN: 2155-384X
Titre abrégé: Clin Transl Gastroenterol
Pays: United States
ID NLM: 101532142

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 2 7 2019
medline: 1 9 2020
entrez: 2 7 2019
Statut: ppublish

Résumé

Loss-of-function mutations of BMPR1A cause juvenile polyposis syndrome (JPS), but large genomic deletions in BMPR1A are rare, reported in few families only, and data regarding the associated phenotype are limited. We investigated clinical features and genomic data of 7 extended seemingly unrelated families with a genomic deletion of the entire coding region of BMPR1A. We defined mutation size, mutation prevalence, and tumor pathogenesis using whole-genome sequencing, targeted genotyping, and haplotype analysis. Patients with JPS from 7 families of Bukharin Jewish ancestry carried a deletion of 429 kb, encompassing the BMPR1A coding sequence and 8 downstream genes. Haplotype analysis and testing controls identified this as a common founder mutation occurring in 1/124 individuals of Bukharin origin. Tumor testing did not demonstrate loss of heterozygosity. Among carriers, JPS was almost fully penetrant, but clinical features varied widely, ranging from mild to very severe, including pan-enteric polyps, gastritis, and colorectal, esophageal, and testicular cancer, and carriers with phenotypes, which would not have raised suspicion of JPS. The phenotype in this large cohort was extremely variable, although all carriers shared the same variant and the same genetic background. New observations include a preponderance of adenomatous rather than juvenile polyps, possible association with testicular cancer, and unexpected upper gastrointestinal involvement.

Identifiants

pubmed: 31259752
doi: 10.14309/ctg.0000000000000054
pmc: PMC6708668
doi:

Substances chimiques

BMPR1A protein, human EC 2.7.11.30
Bone Morphogenetic Protein Receptors, Type I EC 2.7.11.30

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00054

Subventions

Organisme : NCI NIH HHS
ID : R35 CA197458
Pays : United States

Références

Ann Surg Oncol. 1998 Dec;5(8):751-6
pubmed: 9869523
Hum Genet. 2017 Apr;136(4):349-376
pubmed: 28213670
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Am J Gastroenterol. 2009 Dec;104(12):3027-33
pubmed: 19773747
Br J Surg. 2015 Jan;102(1):114-8
pubmed: 25389115
J Med Genet. 2007 Nov;44(11):702-9
pubmed: 17873119
Bioinformatics. 2012 Feb 1;28(3):423-5
pubmed: 22155870
Genes Chromosomes Cancer. 2015 Sep;54(9):575-82
pubmed: 26171675
Bioinformatics. 2013 Aug 15;29(16):2041-3
pubmed: 23736529
Dis Colon Rectum. 2012 Oct;55(10):1038-43
pubmed: 22965402
Cancer Prev Res (Phila). 2011 Oct;4(10):1556-62
pubmed: 21791569
Genet Med. 2016 Oct;18(10):974-81
pubmed: 26845104
Gut. 2007 Jul;56(7):965-7
pubmed: 17303595
Clin Genet. 2009 Jan;75(1):79-85
pubmed: 18823382
Am J Hum Genet. 2006 Sep;79(3):593-6; author reply 596-7
pubmed: 16909400
BMC Genomics. 2011 Apr 12;12:184
pubmed: 21486468
Am J Gastroenterol. 2005 Feb;100(2):476-90
pubmed: 15667510
Hum Pathol. 2016 Mar;49:39-48
pubmed: 26826408
Nat Rev Cancer. 2013 May;13(5):328-41
pubmed: 23612460
Gut. 2008 May;57(5):623-7
pubmed: 18178612

Auteurs

Sari Lieberman (S)

Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.

Rachel Beeri (R)

Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.

Tom Walsh (T)

Departments of Medicine and Genome Sciences, University of Washington, Seattle, Washington, USA.

Menachem Schechter (M)

Gastroenterology Institute, Shaare Zedek Medical Center, Jerusalem, Israel.

Dan Keret (D)

Gastroenterology and Hepatology Department, Clalit Health Services, Jerusalem, Israel.

Elizabet Half (E)

Gastroenterology Institute, Rambam Health Care Campus, Haifa, Israel.

Suleyman Gulsuner (S)

Departments of Medicine and Genome Sciences, University of Washington, Seattle, Washington, USA.

Ariela Tomer (A)

Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.

Harold Jacob (H)

Institute of Gastroenterology and Liver Diseases, Hadassah Medical Center, Jerusalem, Israel.

Shlomi Cohen (S)

Pediatric Gastroenterology Unit, "Dana-Dwek" Children's Hospital, Tel Aviv, Israel.
Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Lina Basel-Salmon (L)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Raphael Recanati Genetics Institute, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
Pediatric Genetics Clinic, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva, Israel.

Mahmud Mansur (M)

Department of Internal Medicine, Hasharon Hospital, Rabin Medical Center, Petah Tikva, Israel.

Rachel Berger (R)

Maccabi Health Services, Rehovot, Israel.

Lior H Katz (LH)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Gastroenterology, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.

Eliahu Golomb (E)

Pathology Department, Shaare Zedek Medical Center, Jerusalem, Israel.

Tamar Peretz (T)

Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.

Zohar Levy (Z)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.

Inbal Kedar (I)

Raphael Recanati Genetics Institute, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.

Mary-Claire King (MC)

Departments of Medicine and Genome Sciences, University of Washington, Seattle, Washington, USA.

Ephrat Levy-Lahad (E)

Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Yael Goldberg (Y)

Raphael Recanati Genetics Institute, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH